Trade IFRX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
InflaRx N.V. (IFRX) is trading at US$2.09, down 1.65% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$309.47M. Over the past 52 weeks, IFRX has traded between US$0.80 and US$2.95. On Syfe you can trade IFRX with $0 commission and add it to your watchlist.
| Previous close | US$2.12 |
|---|---|
| Market cap | US$309.47M |
| 52-week range | US$0.80 – US$2.95 |
| Volume | 345.14K |
| Exchange | US |
Add to Watchlist
Set Price Alert
InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.
Year: 2017
Oppenheimer Adjusts Price Target on InflaRx to $5 From $7, Maintains Outperform Rating
Apr 24, 1:00 PM · MT Newswires
InflaRx N.V. (IFRX) stock is trading at US$2.09, -1.65% from the previous close of US$2.12.
The market cap for InflaRx N.V. (IFRX) stock is approximately US$309.47M.
The 52-week high for InflaRx N.V. (IFRX) stock is US$2.95.
The 52-week low for InflaRx N.V. (IFRX) stock is US$0.80.
InflaRx N.V. (IFRX) does not currently pay a dividend.
Stay on top of IFRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
